Combination therapy of newly diagnosed intermediate-risk pulmonary arterial hypertension: A review
Advancements in the specific therapy of pulmonary arterial hypertension (PAH) and new combination therapy strategies and escalation treatment over the past decade have significantly improved disease control, slowed its progression, and improved fg42 replica quality of life and patient survival.This review provides a detailed discussion of current s